-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Medical Network, August 11 News On August 9, the National Medical Insurance Administration issued a reply to the recommendation No.
4126 of the Fourth Session of the 13th National People's Congress, and received the recommendation made by Representative Lu Qingguo on accelerating the entry of traditional Chinese medicine and formula granules into centralized procurement.
Reply
.
4126 of the Fourth Session of the 13th National People's Congress, and received the recommendation made by Representative Lu Qingguo on accelerating the entry of traditional Chinese medicine and formula granules into centralized procurement.
Reply
.
The original text is as follows:
National Medical Security Administration on the Fourth Session of the 13th National People's Congress
Reply to Recommendation No.
4126
4126
Medical Insurance Letter (2021) No.
28
28
Representative Lu Qingguo:
Your suggestion on accelerating the entry of Chinese medicines and formula granules into centralized procurement has been received.
We have carefully studied it and our reply is as follows:
We have carefully studied it and our reply is as follows:
1.
Progress of centralized drug procurement
Progress of centralized drug procurement
In accordance with the decisions and deployments of the Party Central Committee and the State Council, starting from 2018, the National Medical Insurance Bureau, in conjunction with relevant departments, has promoted the reform of the centralized drug procurement system in an orderly manner, and successfully carried out five batches of 218 drug centralized procurement
.
Under the guidance and promotion of the National Medical Insurance Bureau, all provinces across the country have carried out centralized drug procurement in the form of independent procurement or cross-provincial alliance procurement
.
Concentrated procurement promises to prioritize the use of selected products and ensure the completion of the agreed procurement volume, giving companies stable market expectations, providing companies with a platform for fair competition in the sun, squeezing out the cost of intermediate circulation links, and competition among companies The focus of the company has shifted from the original "rebate competition" to the competition of quality and price, which will help to form a legal and market-oriented good business environment, and it will also help increase industry concentration and promote high-quality development of the industry
.
.
Under the guidance and promotion of the National Medical Insurance Bureau, all provinces across the country have carried out centralized drug procurement in the form of independent procurement or cross-provincial alliance procurement
.
Concentrated procurement promises to prioritize the use of selected products and ensure the completion of the agreed procurement volume, giving companies stable market expectations, providing companies with a platform for fair competition in the sun, squeezing out the cost of intermediate circulation links, and competition among companies The focus of the company has shifted from the original "rebate competition" to the competition of quality and price, which will help to form a legal and market-oriented good business environment, and it will also help increase industry concentration and promote high-quality development of the industry
.
Your suggestion that proprietary Chinese medicines enter the centralized drug procurement as soon as possible , so that more traditional Chinese medicine manufacturers can participate in the competition fairly, we have policy arrangements and preliminary explorations
.
The "Opinions of the General Office of the State Council on Promoting the Normalized and Institutionalized Development of Centralized and Volumetric Procurement of Drugs" (Guobanfa [2021] No.
2) clearly stated that "explore the merger of different generic drugs with similar indications or functions and indications.
"Purchasing with volume" provides basic compliance for the centralized procurement of Chinese patent medicines
.
Currently, Qinghai Province, Zhejiang Jinhua, Puyang, Henan and other places, has for the large part of the demand, as high amounts of the drug to carry out exploration Jicai species, we achieved positive results
.
.
The "Opinions of the General Office of the State Council on Promoting the Normalized and Institutionalized Development of Centralized and Volumetric Procurement of Drugs" (Guobanfa [2021] No.
2) clearly stated that "explore the merger of different generic drugs with similar indications or functions and indications.
"Purchasing with volume" provides basic compliance for the centralized procurement of Chinese patent medicines
.
Currently, Qinghai Province, Zhejiang Jinhua, Puyang, Henan and other places, has for the large part of the demand, as high amounts of the drug to carry out exploration Jicai species, we achieved positive results
.
Second, the next step to consider
We attach great importance to your suggestion of improving the standard system and accelerating the inclusion of proprietary Chinese medicines and formula granules into centralized procurement
.
In the next step, we will work with relevant departments to improve the quality evaluation standards of Chinese patent medicines and formula granules, adhere to quality first, be clinically demand-oriented, start with high-price and large varieties, and scientifically and steadily promote the concentration of Chinese patent medicines and formula granules.
Procurement reform
.
.
In the next step, we will work with relevant departments to improve the quality evaluation standards of Chinese patent medicines and formula granules, adhere to quality first, be clinically demand-oriented, start with high-price and large varieties, and scientifically and steadily promote the concentration of Chinese patent medicines and formula granules.
Procurement reform
.
Medical Network, August 11 News On August 9, the National Medical Insurance Administration issued a reply to the recommendation No.
4126 of the Fourth Session of the 13th National People's Congress, and received the recommendation made by Representative Lu Qingguo on accelerating the entry of traditional Chinese medicine and formula granules into centralized procurement.
Reply
.
4126 of the Fourth Session of the 13th National People's Congress, and received the recommendation made by Representative Lu Qingguo on accelerating the entry of traditional Chinese medicine and formula granules into centralized procurement.
Reply
.
The original text is as follows:
National Medical Security Administration on the Fourth Session of the 13th National People's Congress
Reply to Recommendation No.
4126
4126
Medical Insurance Letter (2021) No.
28
28
Representative Lu Qingguo:
Your suggestion on accelerating the entry of Chinese medicines and formula granules into centralized procurement has been received.
We have carefully studied it and our reply is as follows:
We have carefully studied it and our reply is as follows:
1.
Progress of centralized drug procurement
Progress of centralized drug procurement
In accordance with the decisions and deployments of the Party Central Committee and the State Council, starting from 2018, the National Medical Insurance Bureau, in conjunction with relevant departments, has promoted the reform of the centralized drug procurement system in an orderly manner, and successfully carried out five batches of 218 drug centralized procurement
.
Under the guidance and promotion of the National Medical Insurance Bureau, all provinces across the country have carried out centralized drug procurement in the form of independent procurement or cross-provincial alliance procurement
.
Concentrated procurement promises to prioritize the use of selected products and ensure the completion of the agreed procurement volume, giving companies stable market expectations, providing companies with a platform for fair competition in the sun, squeezing out the cost of intermediate circulation links, and competition among companies The focus of the company has shifted from the original "rebate competition" to the competition of quality and price, which will help to form a legal and market-oriented good business environment, and it will also help increase industry concentration and promote high-quality development of the industry
.
.
Under the guidance and promotion of the National Medical Insurance Bureau, all provinces across the country have carried out centralized drug procurement in the form of independent procurement or cross-provincial alliance procurement
.
Concentrated procurement promises to prioritize the use of selected products and ensure the completion of the agreed procurement volume, giving companies stable market expectations, providing companies with a platform for fair competition in the sun, squeezing out the cost of intermediate circulation links, and competition among companies The focus of the company has shifted from the original "rebate competition" to the competition of quality and price, which will help to form a legal and market-oriented good business environment, and it will also help increase industry concentration and promote high-quality development of the industry
.
Your suggestion that proprietary Chinese medicines enter the centralized drug procurement as soon as possible , so that more traditional Chinese medicine manufacturers can participate in the competition fairly, we have policy arrangements and preliminary explorations
.
The "Opinions of the General Office of the State Council on Promoting the Normalized and Institutionalized Development of Centralized and Volumetric Procurement of Drugs" (Guobanfa [2021] No.
2) clearly stated that "explore the merger of different generic drugs with similar indications or functions and indications.
"Purchasing with volume" provides basic compliance for the centralized procurement of Chinese patent medicines
.
Currently, Qinghai Province, Zhejiang Jinhua, Puyang, Henan and other places, has for the large part of the demand, as high amounts of the drug to carry out exploration Jicai species, we achieved positive results
.
.
The "Opinions of the General Office of the State Council on Promoting the Normalized and Institutionalized Development of Centralized and Volumetric Procurement of Drugs" (Guobanfa [2021] No.
2) clearly stated that "explore the merger of different generic drugs with similar indications or functions and indications.
"Purchasing with volume" provides basic compliance for the centralized procurement of Chinese patent medicines
.
Currently, Qinghai Province, Zhejiang Jinhua, Puyang, Henan and other places, has for the large part of the demand, as high amounts of the drug to carry out exploration Jicai species, we achieved positive results
.
Second, the next step to consider
We attach great importance to your suggestion of improving the standard system and accelerating the inclusion of proprietary Chinese medicines and formula granules into centralized procurement
.
In the next step, we will work with relevant departments to improve the quality evaluation standards of Chinese patent medicines and formula granules, adhere to quality first, be clinically demand-oriented, start with high-price and large varieties, and scientifically and steadily promote the concentration of Chinese patent medicines and formula granules.
Procurement reform
.
.
In the next step, we will work with relevant departments to improve the quality evaluation standards of Chinese patent medicines and formula granules, adhere to quality first, be clinically demand-oriented, start with high-price and large varieties, and scientifically and steadily promote the concentration of Chinese patent medicines and formula granules.
Procurement reform
.
Medical Network, August 11 News On August 9, the National Medical Insurance Administration issued a reply to the recommendation No.
4126 of the Fourth Session of the 13th National People's Congress, and received the recommendation made by Representative Lu Qingguo on accelerating the entry of traditional Chinese medicine and formula granules into centralized procurement.
Reply
.
4126 of the Fourth Session of the 13th National People's Congress, and received the recommendation made by Representative Lu Qingguo on accelerating the entry of traditional Chinese medicine and formula granules into centralized procurement.
Reply
.
The original text is as follows:
The original text is as follows: National Medical Security Administration on the Fourth Session of the 13th National People's Congress
National Medical Security Administration on the Fourth Session of the 13th National People's Congress Reply to Recommendation No.
4126
Reply to Recommendation No. 4126
4126
Medical Insurance Letter (2021) No.
28
Medical Insurance Letter (2021) No. 28
28
Representative Lu Qingguo:
Your suggestion on accelerating the entry of Chinese medicines and formula granules into centralized procurement has been received.
We have carefully studied it and our reply is as follows:
We have carefully studied it and our reply is as follows:
1.
Progress of centralized drug procurement
1. Progress of centralized drug procurement
Progress of centralized drug procurement
In accordance with the decisions and deployments of the Party Central Committee and the State Council, starting from 2018, the National Medical Insurance Bureau, in conjunction with relevant departments, has promoted the reform of the centralized drug procurement system in an orderly manner, and successfully carried out five batches of 218 drug centralized procurement
.
Under the guidance and promotion of the National Medical Insurance Bureau, all provinces across the country have carried out centralized drug procurement in the form of independent procurement or cross-provincial alliance procurement
.
Concentrated procurement promises to prioritize the use of selected products and ensure the completion of the agreed procurement volume, giving companies stable market expectations, providing companies with a platform for fair competition in the sun, squeezing out the cost of intermediate circulation links, and competition among companies The focus of the company has shifted from the original "rebate competition" to the competition of quality and price, which will help to form a legal and market-oriented good business environment, and it will also help increase industry concentration and promote high-quality development of the industry
.
Enterprise business enterprise.
Under the guidance and promotion of the National Medical Insurance Bureau, all provinces across the country have carried out centralized drug procurement in the form of independent procurement or cross-provincial alliance procurement
.
Concentrated procurement promises to prioritize the use of selected products and ensure the completion of the agreed procurement volume, giving companies stable market expectations, providing companies with a platform for fair competition in the sun, squeezing out the cost of intermediate circulation links, and competition among companies The focus of the company has shifted from the original "rebate competition" to the competition of quality and price, which will help to form a legal and market-oriented good business environment, and it will also help increase industry concentration and promote high-quality development of the industry
.
Your suggestion that proprietary Chinese medicines enter the centralized drug procurement as soon as possible , so that more traditional Chinese medicine manufacturers can participate in the competition fairly, we have policy arrangements and preliminary explorations
.
The "Opinions of the General Office of the State Council on Promoting the Normalized and Institutionalized Development of Centralized and Volumetric Procurement of Drugs" (Guobanfa [2021] No.
2) clearly stated that "explore the merger of different generic drugs with similar indications or functions and indications.
"Purchasing with volume" provides basic compliance for the centralized procurement of Chinese patent medicines
.
Currently, Qinghai Province, Zhejiang Jinhua, Puyang, Henan and other places, has for the large part of the demand, as high amounts of the drug to carry out exploration Jicai species, we achieved positive results
.
Purchasing Purchasing Purchasing Drugs Drugs Drugs.
The "Opinions of the General Office of the State Council on Promoting the Normalized and Institutionalized Development of Centralized and Volumetric Procurement of Drugs" (Guobanfa [2021] No.
2) clearly stated that "explore the merger of different generic drugs with similar indications or functions and indications.
"Purchasing with volume" provides basic compliance for the centralized procurement of Chinese patent medicines
.
Currently, Qinghai Province, Zhejiang Jinhua, Puyang, Henan and other places, has for the large part of the demand, as high amounts of the drug to carry out exploration Jicai species, we achieved positive results
.
Second, the next step to consider
Second, the next step to considerWe attach great importance to your suggestion of improving the standard system and accelerating the inclusion of proprietary Chinese medicines and formula granules into centralized procurement
.
In the next step, we will work with relevant departments to improve the quality evaluation standards of Chinese patent medicines and formula granules, adhere to quality first, be clinically demand-oriented, start with high-price and large varieties, and scientifically and steadily promote the concentration of Chinese patent medicines and formula granules.
Procurement reform
.
Standard Standard Standard .
In the next step, we will work with relevant departments to improve the quality evaluation standards of Chinese patent medicines and formula granules, adhere to quality first, be clinically demand-oriented, start with high-price and large varieties, and scientifically and steadily promote the concentration of Chinese patent medicines and formula granules.
Procurement reform
.
